Bladder Cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Male or female patients 20 years of age or older on the day of consent 2.Documented histological or radiological diagnosis of bladder cancer or upper urinary tract cancer without metastasis 3.Voluntary written consent must be given after sufficient explanation with the understanding what this study is and that consent may be withdrawn by the patient at any time without prejudice to future medical care
Exclusion criteria
Exclusion criteria: The patients who are regarded as inappropriate for entering this study by principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary The analysis of the expression of mRNA and miRNA in urine exosome. Secondary The analysis of the association between the expression of the specific marker and the clinical data. | — |
Countries
Japan
Contacts
Hokkaido University Hospital Department of Renal and Genitourinary surgery